Action Summary | Chapter 304 (2021 Acts of Assembly, Special Session I) requires VDH to promulgate regulations to effectuate the act, specifically the specification of prescription drugs for the purpose of data collection and procedures for auditing information provided by health carriers, pharmacy benefits managers, wholesale distributors, and manufacturers, as well as a schedule of civil penalties for failure to report the information required, based on the severity of the violation. As the requirement to report prescription drug price information is new, there is no already existing regulatory chapter that would best fit this mandate, so VDH intends to promulgate a new regulatory chapter for these standards. |
Chapters Affected | Only affects this chapter. |
Executive Branch Review | This action will go through the normal Executive Branch Review process. |
RIS Project | Yes [6828] |
Associated Mandates | Promulgate regulations related to prescription drug pricing transparency reporting |
New Periodic Review | This action will not be used to conduct a new periodic review. |
Name / Title: | Michael Sarkissian / Director, Data and Quality |
Address: |
Virginia Department of Health 109 Governor Street Richmond, VA 23219 |
Email Address: | vdh_oim_regulations@vdh.virginia.gov |
Phone: | (804)864-7416 FAX: (804)864-7022 TDD: ()- |